Osteoporosis Drug Evista Now Being Promoted for Heart Diseasehttp://articles.mercola.com/sites/articles/archive/2002/03/06/evista.aspxThe osteoporosis drug Evista (raloxifene) does not seem to increase the risk of heart attack and other heart problems in women with cardiovascular disease. In fact, raloxifene may offer some protection to women with cardiovascular disease or who are atenCommunityServer 2008.5 SP1 (Build: 31106.3070)